Compare Amylx Pharmaceuticals Inc (AMLX) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Payoneer Global Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Amylx Pharmaceuticals Inc and Payoneer Global Inc are close in size by market cap. Which is the better fit depends on your goals.
| AMLX | PAYO | |
|---|---|---|
Market Cap | $2.64B | $2.40B |
Sector | Health | Technology |
52-Week High | $24.19 | $7.17 |
52-Week Low | $7.82 | $4.27 |
Enterprise Value | $2.39B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
